Denali Therapeutics DNLI
NASDAQ DNLI
$19.73 -0.12 (-0.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Denali Therapeutics (DNLI) Return on Assets [ROA] (2018 - 2026)

Updated

Denali Therapeutics' Return on Assets [ROA] was -42.11% in Q3 2026, up 2.77 percentage points from -44.89% a year earlier and up 0.08 percentage points from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Denali Therapeutics came in at -40.69%, down 7.25 percentage points from FY2024.

  • Return on Assets [ROA] shows a five-year change of -47.29 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Assets [ROA] was -33.45% in FY2024 (-22.34 pp), -11.11% in FY2023 (+11.65 pp), -22.76% in FY2022 (-3.44 pp) and -19.32% in FY2021 (-25.91 pp).
  • The Q3 2026 figure marks the highest quarterly Return on Assets [ROA] since Q2 2025.
  • Compared with a year earlier, Return on Assets [ROA] was higher in 1 of the last eight quarters, with an average year-over-year change of -11.84 percentage points.
  • The best year-over-year quarter for Return on Assets [ROA] over five years was Q1 2024 (a gain of 15.79 percentage points); the worst was Q3 2022 (a drop of 26.11 percentage points).
  • Per Business Quant data, DNLI's Return on Assets [ROA] in the three quarters before Q3 2026 was -42.19% (Q2 2026), -42.14% (Q1 2026) and -46.58% (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 19.00%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 8.08%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 7.32%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 1.87%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.36%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 9.80%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -7.67%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 2.00%
10 Denali Therapeutics 3.18 Bn 98.89 Mn 17.59 Mn -42.38%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -42.38%
Jun 30, 2026 -42.44%
Mar 31, 2026 -42.37%
Dec 31, 2025 -46.71%
Sep 30, 2025 -45.29%
Jun 30, 2025 -39.01%
Mar 31, 2025 -34.07%
Dec 31, 2024 -29.80%
Sep 30, 2024 -8.03%
Jun 30, 2024 -7.67%
Mar 31, 2024 12.11%
Dec 31, 2023 13.71%
Sep 30, 2023 -8.99%
Jun 30, 2023 -8.74%
Mar 31, 2023 -25.36%
Dec 31, 2022 -24.58%
Sep 30, 2022 -24.91%
Jun 30, 2022 -22.64%
Mar 31, 2022 -21.63%
Dec 31, 2021 -20.52%
API Access

Denali Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DNLI&period=max&api_key=YOUR_API_KEY